Researchers at IVF treatment clinic Care Facility found that around 44 percent of their patients seeking IVF treatment carried a faulty gene, called C4/M2 that was responsible for repeated miscarriages. Providing the blood thinning treatment can fix the faulty gene, significantly reduce the risk of repeated miscarriages and increase the healthy baby birth rate to 38 per cent.
"It's blood thinning treatment - it's a drug called heparin - possibly even aspirin, but we're studying that at the moment. Those women who have had very poor prognosis can now have the chance of a live birth similar to people who don't have this problem. We studied our IVF patients and found that 44 per cent of couples carried the gene. This is the first time in the world where it has been found that a man can carry a gene that can pass on miscarriage to a woman", Care Facility managing director Professor Simon Fishel said.